These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8624072)

  • 1. Regulation of tau phosphorylation in Alzheimer's disease.
    Lee VM
    Ann N Y Acad Sci; 1996 Jan; 777():107-13. PubMed ID: 8624072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
    Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH
    J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.
    Guimarães TR; Swanson E; Kofler J; Thathiah A
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):942-957. PubMed ID: 34164834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis review: Alzheimer's overture guidelines.
    Ferrer I
    Brain Pathol; 2023 Jan; 33(1):e13122. PubMed ID: 36223647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonopathy Likely Initiates Neuropathological Processes Via a Mechanism of Axonal Leakage in Alzheimer's Mouse Models.
    Gao G; He J; Luo Y; Sun Y; Zhou Y; Zhang J; Xing Y; Dai J
    Curr Mol Med; 2019; 19(3):183-195. PubMed ID: 30961496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptors and tau phosphorylation.
    Rubio A; Pérez M; Avila J
    Curr Mol Med; 2006 Jun; 6(4):423-8. PubMed ID: 16900665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
    Avila J; Lim F; Moreno F; Belmonte C; Cuello AC
    Mol Neurobiol; 2002 Jun; 25(3):213-31. PubMed ID: 12109872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
    Trojanowski JQ; Lee VM
    FASEB J; 1995 Dec; 9(15):1570-6. PubMed ID: 8529836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.